论文部分内容阅读
目的:分析低分子肝素治疗肺心病心力衰竭临床效果。方法:82例法肺心病心力衰竭患者随机分为对比组和研究组,对比两组的临床效果。结果:研究组的治疗效果明显优于对比组。其中对比组的患者治疗有效人数共为6例,治疗显效22例,治疗无效共13例,对比组的治疗总有效率为68.29%;研究组患者治疗有效人数共为8例,治疗显效例31例,治疗无效共2例,研究组的治疗总有效率为95.12%,差异具有统计学意义(P<0.05)。结论:对肺心病心力衰竭患者采用常规治疗加低分子肝素治疗,临床效果明显。
Objective: To analyze the clinical effect of low molecular weight heparin in treating heart failure with pulmonary heart disease. Methods: 82 patients with cor pulmonale heart failure were randomly divided into control group and study group, comparing the clinical effect of the two groups. Results: The treatment effect of the study group was obviously better than that of the control group. Among the patients in the control group, the effective number of patients was 6, the treatment was effective in 22 cases, the treatment of ineffective total of 13 cases, the control group, the total effective rate was 68.29%; the study group of patients treated a total of 8 cases, 31 Cases, the treatment was invalid in 2 cases, the study group’s total effective rate was 95.12%, the difference was statistically significant (P <0.05). Conclusion: The treatment of heart failure patients with pulmonary heart disease with conventional treatment plus low molecular weight heparin therapy, the clinical effect is obvious.